Advances in molecular diagnostics for mitochondrial diseases

Area of Science:

• Biochemistry
• Genetics
• Medical Diagnostics

Background:

• Mitochondrial disorders (MD) stem from impaired mitochondrial respiratory chains, presenting diverse phenotypes from myopathy to multisystemic conditions.
• Genetic defects in MD can reside in mitochondrial or nuclear DNA, necessitating a multifaceted diagnostic approach.
• Current diagnostic methods include serum lactate, electromyography, muscle histology/enzymology, and genetic analysis, with magnetic resonance spectroscopy aiding metabolic assessment.

Purpose of the Study:

• To review the role and advancements in diagnostic techniques for mitochondrial disorders (MD).
• To highlight how molecular and genetic characterization, alongside other experimental methods, offers new insights into MD.
• To underscore the ongoing need for reliable biomarkers for MD screening and diagnosis.

Main Methods:

• Review of current diagnostic approaches for MD, including invasive and non-invasive techniques.
• Exploration of molecular and genetic characterization methods for identifying disease-causing defects.
• Assessment of emerging technologies like magnetic resonance spectroscopy and soluble molecular markers.

Main Results:

• Existing diagnostic protocols for MD are complex and require a combination of clinical, histological, and genetic evaluations.
• Magnetic resonance spectroscopy provides valuable data for diagnosing and monitoring MD by assessing tissue metabolic alterations.
• While molecular markers can indicate aerobic system impairment, a definitive screening biomarker for MD remains elusive.

Conclusions:

• New molecular investigative approaches are crucial for advancing the understanding and diagnosis of MD.
• The insights gained from these molecular techniques hold potential for guiding future therapeutic strategies in MD.
• Continued research into novel biomarkers and diagnostic tools is essential for improving patient outcomes in mitochondrial disorders.